Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-24

FDA Approved: EDLUAR — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for Edluar (zolpidem tartrate) submitted by Viatris Specialty LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EDLUAR (ZOLPIDEM TARTRATE)

Snippet

SUPPL AP for EDLUAR (ZOLPIDEM TARTRATE)